Monoclonal antibodies (MoAbs) targeting the common acute lymphoblastic leukemia antigen (CALLA) did not impair polymorphonuclear (PMN) leukocyte function. This finding supports the use of CALLA MoAbs in acute lymphoblastic leukemia (ALL) serotherapy and host defense research.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: